UK lab-in-a-bead co attracts £2m-plus investment:
This article was originally published in Clinica
Executive Summary
Cardiff, UK-based start-up Q Chip, which is developing its ReaX portfolio of customised bead-based, ready-assembled reagents for simplified and accurate DNA testing, has clinched over £2m ($4m) in it latest fundraising round. The proceeds will be used to accelerate product development, sale and marketing activities and expand the company's production capacity. The financing came from new investors Forum des Entrepreneurs (Geneva, Switzerland), the Sustainable Technology Fund and Finance Wales (both UK-based). Existing shareholders E-Synergy's Early Growth Fund, Biofusion and Jon Moulton (managing partner of private equity firm Alchemy Partners) also participated in the round.
You may also be interested in...
EU Regulatory Assessors Get AI Boost In Reaching Scientific Decisions
The European Medicines Agency is training scientific staff working for the European medicines regulatory network in how to use a new AI-powered search engine that allows them to easily retrieve information on regulatory precedents.
EU Parliament Stricter Than Council On Medicines And Medical Devices Packaging
The EU Parliament's Environment, Public Health and Food Safety committee takes a compromise position with regards to the Packaging and Packaging Waste Directive. Medicines and medical devices should be exempt, but only until 2035, at which point the European Commission should check whether the development of materials and the recycling process have progressed, and may adjust this exemption accordingly.
Stay Or Exit? Global Health Players Ponder New China Trajectory
It's again the time of year when global CEOs descend on China's capital to discuss strategies. This year, however, the mood is different.